The 50-minute session will focus on safety concerns with labelling of IV fluids, strategies to mitigate fluoropyrimidine toxicity and the National System for Incident Reporting transition.
A study conducted in Ontario shows that the use of first-generation antihistamines increases the risk of delirium in hospitalized seniors—calling for a review of certain prescribing practices.